MET Amplification and Efficacy of Nivolumab in Patients With NSCLC

INTRODUCTION: MET amplification is an important genetic alteration in NSCLC. Unlike in patients with EGFR and ALK alterations, the efficacy of immune checkpoint inhibitors in patients with MET-amplified NSCLC remains unknown. METHODS: An exploratory analysis of a prospective, multi-institutional coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Katsuhiro, Inoue, Yusuke, Inui, Naoki, Karayama, Masato, Yasui, Hideki, Hozumi, Hironao, Suzuki, Yuzo, Furuhashi, Kazuki, Fujisawa, Tomoyuki, Enomoto, Noriyuki, Nakamura, Yutaro, Sugimura, Haruhiko, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569583/
https://www.ncbi.nlm.nih.gov/pubmed/34766065
http://dx.doi.org/10.1016/j.jtocrr.2021.100239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569583/
https://www.ncbi.nlm.nih.gov/pubmed/34766065
http://dx.doi.org/10.1016/j.jtocrr.2021.100239

Ejemplares similares